To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Webster Equity’s Bristol Hospice preps sale process
The upcoming process for Bristol comes as Webster runs a secondaries process for two existing Fund III portfolio companies: BayMark and Pharmalogic.
